| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | Adrenergic signaling in cardiomyocytes 7 genes, 6 drugs (DrugBank), 25 diseases shown |
[1] ADRB1 |
D00235 |
Atenolol |
[1] 167 |
| D05127 |
Nebivolol |
[3] 17, 113, 167 |
| [2] ADRB1, ADRB2 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| [1] AGTR1 |
D00523 |
Irbesartan |
[4] 66, 167, 168, 222 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 2 | AGE-RAGE signaling pathway in diabetic complications 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] AGTR1 |
D00523 |
Irbesartan |
[4] 66, 167, 168, 222 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 3 | Aldosterone synthesis and secretion 5 genes, 3 drugs (DrugBank), 21 diseases shown |
[1] AGTR1 |
D00523 |
Irbesartan |
[4] 66, 167, 168, 222 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 4 | Alzheimer disease 4 genes, 1 drug (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 5 | Amphetamine addiction 2 genes, 1 drug (DrugBank), 4 diseases shown |
[2] CACNA1C, CACNA1D |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 6 | Apelin signaling pathway 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] AGTR1 |
D00523 |
Irbesartan |
[4] 66, 167, 168, 222 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) 4 genes, 1 drug (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 8 | Calcium signaling pathway 8 genes, 6 drugs (DrugBank), 25 diseases shown |
[1] ADRB1 |
D00235 |
Atenolol |
[1] 167 |
| D05127 |
Nebivolol |
[3] 17, 113, 167 |
| [3] ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| [1] AGTR1 |
D00523 |
Irbesartan |
[4] 66, 167, 168, 222 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 9 | cAMP signaling pathway 6 genes, 4 drugs (DrugBank), 10 diseases shown |
[1] ADRB1 |
D00235 |
Atenolol |
[1] 167 |
| D05127 |
Nebivolol |
[3] 17, 113, 167 |
| [2] ADRB1, ADRB2 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 10 | Carbohydrate digestion and absorption 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] CACNA1D |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 11 | Cardiac muscle contraction 4 genes, 1 drug (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 12 | Cellular senescence 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] CACNA1D |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 13 | cGMP-PKG signaling pathway 8 genes, 6 drugs (DrugBank), 25 diseases shown |
[1] ADRB1 |
D00235 |
Atenolol |
[1] 167 |
| D05127 |
Nebivolol |
[3] 17, 113, 167 |
| [3] ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| [1] AGTR1 |
D00523 |
Irbesartan |
[4] 66, 167, 168, 222 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 14 | Chagas disease (American trypanosomiasis) 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ACE |
D00624 |
Perindopril |
[2] 167, 222 |
| D03753 |
| 15 | Cholinergic synapse 4 genes, 1 drug (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 16 | Circadian entrainment 2 genes, 1 drug (DrugBank), 4 diseases shown |
[2] CACNA1C, CACNA1D |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 17 | Cortisol synthesis and secretion 5 genes, 3 drugs (DrugBank), 21 diseases shown |
[1] AGTR1 |
D00523 |
Irbesartan |
[4] 66, 167, 168, 222 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 18 | Cushing syndrome 5 genes, 3 drugs (DrugBank), 21 diseases shown |
[1] AGTR1 |
D00523 |
Irbesartan |
[4] 66, 167, 168, 222 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 19 | Dilated cardiomyopathy (DCM) 5 genes, 4 drugs (DrugBank), 10 diseases shown |
[1] ADRB1 |
D00235 |
Atenolol |
[1] 167 |
| D05127 |
Nebivolol |
[3] 17, 113, 167 |
| D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 20 | Dopaminergic synapse 2 genes, 1 drug (DrugBank), 4 diseases shown |
[2] CACNA1C, CACNA1D |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 21 | GABAergic synapse 4 genes, 1 drug (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 22 | Gap junction 1 gene, 3 drugs (DrugBank), 7 diseases shown |
[1] ADRB1 |
D00235 |
Atenolol |
[1] 167 |
| D05127 |
Nebivolol |
[3] 17, 113, 167 |
| D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| 23 | Glutamatergic synapse 2 genes, 1 drug (DrugBank), 4 diseases shown |
[2] CACNA1C, CACNA1D |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 24 | GnRH secretion 4 genes, 1 drug (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 25 | GnRH signaling pathway 4 genes, 1 drug (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 26 | Growth hormone synthesis, secretion and action 4 genes, 1 drug (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 27 | Hypertrophic cardiomyopathy (HCM) 5 genes, 2 drugs (DrugBank), 5 diseases shown |
[1] ACE |
D00624 |
Perindopril |
[2] 167, 222 |
| D03753 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 28 | Insulin secretion 4 genes, 1 drug (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 29 | Long-term potentiation 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] CACNA1C |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 30 | MAPK signaling pathway 4 genes, 1 drug (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 31 | Neuroactive ligand-receptor interaction 4 genes, 5 drugs (DrugBank), 23 diseases shown |
[1] ADRB1 |
D00235 |
Atenolol |
[1] 167 |
| D05127 |
Nebivolol |
[3] 17, 113, 167 |
| [3] ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| [1] AGTR1 |
D00523 |
Irbesartan |
[4] 66, 167, 168, 222 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 32 | Oxytocin signaling pathway 4 genes, 1 drug (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 33 | Pathways in cancer 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] AGTR1 |
D00523 |
Irbesartan |
[4] 66, 167, 168, 222 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 34 | Phospholipase D signaling pathway 1 gene, 2 drugs (DrugBank), 19 diseases shown |
[1] AGTR1 |
D00523 |
Irbesartan |
[4] 66, 167, 168, 222 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 35 | Regulation of lipolysis in adipocytes 3 genes, 3 drugs (DrugBank), 7 diseases shown |
[1] ADRB1 |
D00235 |
Atenolol |
[1] 167 |
| D05127 |
Nebivolol |
[3] 17, 113, 167 |
| [3] ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| 36 | Renin secretion 10 genes, 8 drugs (DrugBank), 25 diseases shown |
[1] ACE |
D00624 |
Perindopril |
[2] 167, 222 |
| D03753 |
| [1] ADRB1 |
D00235 |
Atenolol |
[1] 167 |
| D05127 |
Nebivolol |
[3] 17, 113, 167 |
| [3] ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| [1] AGTR1 |
D00523 |
Irbesartan |
[4] 66, 167, 168, 222 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| [1] REN |
D03208 |
Aliskiren |
[3] 66, 167, 222 |
| 37 | Renin-angiotensin system 3 genes, 4 drugs (DrugBank), 19 diseases shown |
[1] ACE |
D00624 |
Perindopril |
[2] 167, 222 |
| D03753 |
| [1] AGTR1 |
D00523 |
Irbesartan |
[4] 66, 167, 168, 222 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [1] REN |
D03208 |
Aliskiren |
[3] 66, 167, 222 |
| 38 | Retrograde endocannabinoid signaling 4 genes, 1 drug (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 39 | Salivary secretion 3 genes, 3 drugs (DrugBank), 7 diseases shown |
[1] ADRB1 |
D00235 |
Atenolol |
[1] 167 |
| D05127 |
Nebivolol |
[3] 17, 113, 167 |
| [3] ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| 40 | Serotonergic synapse 4 genes, 1 drug (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 41 | Taste transduction 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] CACNA1C |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 42 | Thermogenesis 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] ADRB3 |
D00483 |
Propranolol |
[5] 6, 158, 167, 227, 278 |
| D08443 |
| 43 | Tight junction 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] CACNA1D |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 44 | Type II diabetes mellitus 2 genes, 1 drug (DrugBank), 4 diseases shown |
[2] CACNA1C, CACNA1D |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |
| 45 | Vascular smooth muscle contraction 5 genes, 3 drugs (DrugBank), 21 diseases shown |
[1] AGTR1 |
D00523 |
Irbesartan |
[4] 66, 167, 168, 222 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
[4] 96, 130, 140, 167 |
| D02356 |